INmune Bio, Inc.INMBNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending lower, above historical average.
Left:
||||
Price-to-book ratio
Latest
2.90
↑ 101% above average
Average (9y)
-236.06
Historical baseline
Range
High:5.42
Low:-2117.42
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 2.90 | -45.3% |
| 2023 | 5.31 | +180.7% |
| 2022 | 1.89 | -7.8% |
| 2021 | 2.05 | -61.5% |
| 2020 | 5.33 | +111.1% |
| 2019 | 2.52 | -53.4% |
| 2018 | 5.42 | +9.5% |
| 2017 | 4.95 | +101.8% |
| 2016 | -273.56 | +87.1% |
| 2015 | -2117.42 | - |